![Matthias Guckenberger: Cancer trial participation not associated with longer OS compared to routine care](https://oncodaily.com/pub/uploads/2024/06/IMG_3327-1-1280x548.jpeg)
Jun 18, 2024, 18:23
Matthias Guckenberger: Cancer trial participation not associated with longer OS compared to routine care
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X:
“Cancer trial participation not associated with longer OS compared to routine care.
Motivation for patients:
- Potential benefits other than OS eg structured care protocols.
- To contribute to a better treatment for FUTURE patients.”
Additional information.
Source: Matthias Guckenberger/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 8, 2024, 16:35
Sep 8, 2024, 16:11
Sep 8, 2024, 16:01
Sep 8, 2024, 15:30
Sep 8, 2024, 14:55
Sep 8, 2024, 14:49
Sep 8, 2024, 14:47